1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow chiauranib: new trials by email Literature Review of chiauranib trials Research Report on chiauranib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Chiauranib, Toripalimab Injection, Albumin-paclitaxel Injection - Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | Not yet recruiting | Chipscreen Biosciences, Ltd. | 558 | 2026-03-31 | 2026-03-03 |
| Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer chiauranib, Placebo, Paclitaxel - Ovarian Cancer, Relapsed or Refractory | Phase 3 | Recruiting | Chipscreen Biosciences, Ltd. | 454 | 2021-12-20 | 2024-10-18 |
| Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer Chiauranib, Placebo - Small Cell Lung Cancer | Phase 3 | Completed | Chipscreen Biosciences, Ltd. | 184 | 2021-03-05 | 2024-12-09 |
Ovarian Neoplasms (1) · Recurrence (1) · Small Cell Lung Carcinoma (1)
Chipscreen Biosciences, Ltd. (3)
China (3)
Xiaohua Wu (1) · Yuankai Shi (1)